Using salmeterol xinafoate (SX) as an active pharmaceutical ingredient, the effects of carrier lactose particle type, total lactose fines content and device resistance on dry powder inhaler performance were investigated in vitro. To mimic drug levels in commercial preparations, interactive mixtures containing 0.58% w/w SX were prepared by low shear tumble mixing. Three types of milled inhalation grade lactose were used (Lactohale(®) LH 200, Respitose(®) ML006 and ML001) and the concentration of fine lactose (Lactohale(®) 300) added was varied. The in vitro deposition of each mixture was studied using a next generation impactor and inhaler devices exhibiting different resistances, Rotahaler(®)80% ED and MMAD ± GSD between 1-5 μm. The results confirmed the factors under investigation to be important determinants of product performance, but demonstrated using realistic conditions how individual factor impact may be enhanced or mitigated by inter-dependency.

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.ijpharm.2015.05.028DOI Listing

Publication Analysis

Top Keywords

salmeterol xinafoate
8
dry powder
8
lactose lactohale®
8
formulating powder-device
4
powder-device combinations
4
combinations salmeterol
4
xinafoate dry
4
powder inhalers
4
inhalers salmeterol
4
xinafoate active
4

Similar Publications

Article Synopsis
  • G-protein-coupled receptors (GPCRs), especially the β2-adrenergic receptor (β2AR), are vital for drug targeting in treating pulmonary diseases.
  • Our study used coarse-grained molecular dynamics simulations to analyze how salmeterol and salbutamol interact with membranes and the β2AR, revealing that drug molecules often use the receptor surface for better membrane permeability.
  • Findings indicate that enhancing drug interactions with GPCR surfaces could improve therapeutic effectiveness, presenting new avenues for drug development.
View Article and Find Full Text PDF

New ways to repurpose salmeterol in an animal model of fibromyalgia.

Fundam Clin Pharmacol

February 2025

Department of Pharmacology and Toxicology, Faculty of Pharmacy, Cairo University, Cairo, 11562, Egypt.

Article Synopsis
  • Fibromyalgia (FM) is a chronic pain syndrome linked to mood issues, sleep problems, and cognitive decline, possibly due to central pain processing dysfunction and neurotransmitter imbalances.* -
  • In a study involving rats, reserpine was used to induce FM-like symptoms, revealing issues like increased pain sensitivity, depressive behaviors, and biochemical disturbances, which were reversed with the administration of salmeterol, a β2 receptor agonist.* -
  • The findings suggest that treatments targeting β2 receptors, like salmeterol, could be an effective approach for managing symptoms associated with fibromyalgia.*
View Article and Find Full Text PDF

Purpose: For locally-acting dry powder inhalers (DPIs), developing novel analytical tools that are able to evaluate the state of aggregation may provide a better understanding of the impact of material properties and processing parameters on the in vivo performance. This study explored the utility of the Morphologically-Directed Raman Spectroscopy (MDRS) and dissolution as orthogonal techniques to assess microstructural equivalence of the aerosolized dose of DPIs collected with an aerosol collection device.

Methods: Commercial DPIs containing different strengths of Fluticasone Propionate (FP) and Salmeterol Xinafoate (SX) as monotherapy and combination products were sourced from different regions.

View Article and Find Full Text PDF

Objective: To observe the effect of low-dose azithromycin on pulmonary ventilation function and inflammatory factors IL-6, IL-13 in children with bronchial asthma.

Methods: A total of 80 children with asthma in Pediatric Medicine affiliated to Taizhou Women and Children's Hospital of Wenzhou Medical University from January 2019 to December 2022 were selected and divided into control group (42 cases) and study group (38 cases). The control group regularly inhaled Salmeterol Xinafoate and Fluticasone Propionate inhalation, while the study group was additionally given low-dose azithromycin.

View Article and Find Full Text PDF
Article Synopsis
  • The study aimed to compare the effectiveness of inhaled salbutamol versus salmeterol in treating arterial hypoxaemia in anesthetized horses.
  • A total of 108 horses were anesthetized for various procedures and randomly given either salbutamol or salmeterol if their oxygen levels dropped below a specific threshold.
  • Results showed that salbutamol was significantly more effective, with a higher percentage of horses showing improvements in oxygen levels compared to those treated with salmeterol.
View Article and Find Full Text PDF

Want AI Summaries of new PubMed Abstracts delivered to your In-box?

Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!